Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q2 2018 call → NOWe need answer YES/NO. Need analyze transcript. Need determine if management describes company currently living through defined waiting period paying out of pocket, benefit not arrived, end specific near-dated event, work in motion. Need identify one coherent situation. Transcript: restructuring program $50 million, operational assessment, 100 projects, improve cost structure $45 million total, $15 million benefit in 2019, incremental $30 million in 2020, more than 200 bps margin expansion. They recorded $8.5 million expense in Q2. They are implementing projects. This is a program with costs now, benefits later. Is it a defined waiting period? They are paying restructuring costs now, benefits in 2019 and 2020. End? They expect $15 million benefit in 2019, incremental $30 million in 2020. But is that near-dated? 2019/2020. They will provide framework at Technology Day in September. They are currently incurring restructuring charges. Is this "paying now for something not yet earning"? Yes, restructuring costs are real, currently landing. They are funding it themselves. Management speaks as though getting through this interval is main current work? They introduced program, implementing projects, remain confident. They don't apologize. Far side specific near-dated? Benefits in 2019 and 2020, but not a single event? It's a program with phased benefits. The question asks "defined waiting period" with end specific near-dated event. Restructuring program has benefits in 2019 and 2020, not necessarily a single crossing. But maybe "Technology Day in September" to provide updated framework through 2020. However, the cost is restructuring charge, and benefit is cost savings. Is that a waiting period? They are paying now for something not yet earning? Restructuring costs are one-time, benefits future. But is it "currently living through a defined waiting period" with end near-dated? The benefits start in 2019, incremental in 2020. The far side is not a single event but a multi-year benefit. Also, the cost is not "paying for something not yet earning" in sense of asset being built; it's restructuring expense to improve cost structure. It is a program, not a waiting period.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.